Skip to Main Content

Paper Details

Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients.
Transpl Infect Dis
5
2021
CMV, CMV DNAemia, Cytomegalovirus, Cytomegalovirus (CMV) infection, DNAemia, Patients, cytomegalovirus DNAemia, patient, patients, renal insufficiency, valganciclovir
Author NameAffiliation
Joanna SchaenmanDavid Geffen School of Medicine
Joanna SchaenmanDavid Geffen School of Medicine
Elaine F ReedDavid Geffen School of Medicine
Elaine F ReedDavid Geffen School of Medicine
  • 1 - 4

Datasets

Release 1.2